Targeted protein degradation is largely performed by the ubiquitin-proteasome pathway, in which substrate proteins are marked by covalently attached ubiquitin chains that mediate recognition by the proteasome. It is currently unclear how the proteasome recognizes its substrates, as the only established ubiquitin receptor intrinsic to the proteasome is Rpn10/S5a (ref. 1), which is not essential for ubiquitin-mediated protein degradation in budding yeast 2 . In the accompanying manuscript we report that Rpn13 (refs 3-7), a component of the nine-subunit proteasome base, functions as a ubiquitin receptor 8 , complementing its known role in docking de-ubiquitinating enzyme Uch37/UCHL5 (refs 4-6) to the proteasome. Here we merge crystallography and NMR data to describe the ubiquitin-binding mechanism of Rpn13. We determine the structure of Rpn13 alone and complexed with ubiquitin. The co-complex reveals a novel ubiquitin-binding mode in which loops rather than secondary structural elements are used to capture ubiquitin. Further support for the role of Rpn13 as a proteasomal ubiquitin receptor is demonstrated by its ability to bind ubiquitin and proteasome subunit Rpn2/S1 simultaneously. Finally, we provide a model structure of Rpn13 complexed to diubiquitin, which provides insights into how Rpn13 as a ubiquitin receptor is coupled to substrate deubiquitination by Uch37.
the first 21 amino-and last 20 carboxy-terminal amino acids are unstructured, residues 22-130 form a PHD fold. This result was surprising, as primary sequence alignment did not identify Rpn13 as being homologous to previously characterized proteins. This finding, coupled with its ubiquitin receptor properties 8 , prompted us to name the N-terminal domain of Rpn13 pleckstrin-like receptor for ubiquitin (Pru).
Though very divergent at their sequence level, all PHDs have a common b-sandwich fold. The PHD of Rpn13 is composed of a four-stranded twisted antiparallel b-sheet (b [1] [2] [3] [4] : residues 22-34, 45-52, 56-62, 71-74) that packs almost orthogonally against a second triple-stranded b-sheet (b [5] [6] [7] : residues 80-85, 92-98, 103-110) ( Supplementary Fig. 1 ). Like other PHDs, Rpn13 Pru forms a hydrophobic core containing conserved hydrophobic residues (F26, V47, I49, F59, F82, Y94, L96, F107 and M109), which are located within b-sheets. One end of the b-sandwich is capped by a long C-terminal amphipathic a-helix (residues 117-128), which is stabilized by interactions between V124 and L128, whereas the other corner of the hydrophobic core is closed by three loops formed by residues located between strands S1/S2, S3/S4 and S6/S7 ( Fig. 1a and Supplementary Fig. 1 ).
Despite much effort, we were unable to crystallize the Rpn13 Pruubiquitin complex; however, we determined the structure of this complex by molecular docking, based on the crystal structure of mRpn13 Pru and intermolecular nuclear Overhauser enhancements (NOEs) as well as data from chemical shift perturbation derived by NMR titration experiments. The topology of the complexed structure was readily defined by 12 unambiguous intermolecular NOE interactions between human Rpn13 (hRpn13) Pru and ubiquitin (Fig. 2a) . We were able to use the hRpn13:ubiquitin NOEs with the mRpn13 crystal structure because all of the amino acids exhibiting intermolecular NOEs are strictly conserved between murine and human Rpn13. Importantly, the mRpn13 Pru-ubiquitin structure reveals a novel ubiquitin-binding mode in which residues of the S2-S3, S4-S5 and S6-S7 loops capture ubiquitin (Fig. 2b) . At the core of the contact surface, hydrogen bonds are formed between sidechain oxygens of D78 and D79 in hRpn13, and Ne2 and Nd1 of H68 in ubiquitin, respectively. Moreover, F76 engages in hydrophobic interactions with I44, Q49 and V70 of ubiquitin ( Supplementary   Fig. 2 ). These contacts are enabled by the strictly conserved P77, which causes the S4-S5 loop to turn. The intermolecular NOE data for this complex were fully satisfied without Rpn13 Pru or ubiquitin structural rearrangements, and the root mean squared deviations between the free and complexed state of Rpn13 Pru and ubiquitin were 0.91 and 0.75 Å for backbone atoms, and 1.20 and 1.15 Å for all non-hydrogen atoms, respectively.
Additional hydrophobic contacts exist, as Rpn13's side-chain methyl group of A100 and the Ca group of G101 partly bury ubiquitin's F45, which is solvent-exposed in the free protein. Similarly, Rpn13's strictly conserved F98 located on S6 also becomes less b, Stereo representation of the mRpn13 Pru-ubiquitin complex oriented with ubiquitin at the top. At the interaction surface, secondary structural elements of ubiquitin and Rpn13 Pru are displayed in green and blue, respectively. Residues at the contact surface with intermolecular NOEs are in yellow (ubiquitin) or red (Rpn13 Pru), whereas those suggested to be at the contact surface only by the NMR titration experiments are displayed in purple (ubiquitin) or cyan (Rpn13 Pru). M31, C88 and E111, which shift upon hRpn2 (amino acids 797-953) addition, are displayed in dark green. c, Specific amino-acid substitutions were made within the S2-S3, S4-S5 and S6-S7 loops of mRpn13 Pru by in vitro mutagenesis. The protein products were expressed as GST fusions and used in GST pull-down assays to highlight the importance of these loops for tetraubiquitin binding. d, Ubiquitin (blue), hRpn2 (amino acids 797-953) (green) or ubiquitin and hRpn2 (amino acids 797-953) (red) were added to the hRpn13 Pru domain, which was monitored by 1 H, 15 N heteronuclear single-quantum coherence experiments. Comparison with the spectrum acquired on the protein alone (black) indicates that S55, F76 and D78 bind ubiquitin in a manner that is independent of hRpn2 (amino acids 797-953), whereas M31, C88 and E111 bind hRpn2 in a ubiquitin-independent manner. solvent-accessible through interactions with A46 and G47 of ubiquitin. Calculation of the electrostatic potential of mRpn13 illustrates that a hydrophobic region within its ubiquitin-binding surface that contains L56 and F76 is available to interact with ubiquitin's L8, I44 and V70 ( Supplementary Fig. 3 ). Complementary electrostatic interactions between Rpn13 Pru and ubiquitin also stabilize the complex, including interactions of D78 and D79 of Rpn13 Pru with ubiquitin's H68, as well as D53 and D54 with ubiquitin's R42 and R72.
In total, the contact surface of Rpn13 Pru and ubiquitin comprises 1256 Å 2 , which is large for ubiquitin receptors. Thus, the relatively high affinity of hRpn13 binding to monoubiquitin 8 is partly explained by the enlarged contact surface compared with that of EAP45 GLUE (1000 Å 2 in total) 9 . Published values for the total buried surface of Cue2-1 cue and Dsk2 UBA upon ubiquitin binding are even smaller: 960 and 800 Å 2 , respectively 10, 11 . To analyse the significance of specific interactions identified in the mRpn13-ubiquitin complex, we made several amino-acid substitutions including L56A, I75R, F76R, D79N and F98R. The ubiquitin-binding competency of the resulting amino-acidsubstituted proteins was tested by using GST-4xUb (created by the in-frame expression of glutathione S-transferase (GST) and four ubiquitin sequences) in pull-down assays (Fig. 2c) . These experiments validated our mRpn13-ubiquitin structure and provided strong evidence for the importance of the S2-S3, S4-S5 and S6-S7 loops in ubiquitin binding by mRpn13. In particular, the single amino-acid substitutions L56A, I75R, F76R and F98R abrogate ubiquitin binding, and a strong reduction is observed for the D79N mutation. We tested how three of these mutations affect mRpn13 structural integrity. In particular, NMR experiments were performed on mRpn13 Pru with the L56A, F76R or D79N mutations incorporated and compared with the wild-type mRpn13 Pru domain. These comparisons demonstrated that the loss of ubiquitin binding was not caused by loss of structural integrity ( Supplementary Fig. 4) . Altogether, our results demonstrate that ubiquitin binding is defined by key interactions with residues within the S2-S3, S4-S5 and S6-S7 loops.
To function as a proteasomal ubiquitin receptor, Rpn13 must bind ubiquitin and proteasome components simultaneously. In yeast and mammals, Rpn13 binds to Rpn2 through its Pru domain 5, 12, 13 . Although the Pru domain also binds ubiquitin, we found that Rpn2 binding does not disturb the Rpn13 loops that bind ubiquitin. By using a nested set of N-terminal deletions in human Rpn2 (hRpn2), we determined a fragment spanning amino acids 797-953 to bind mRpn13 ( Supplementary Fig. 5 ). The addition of this fragment (hRpn2 (797-953)) to hRpn13 did not affect residues at the ubiquitin contact surface, which shift only upon ubiquitin addition, as demonstrated for S55, F76 and D78 (Fig. 2d) . By contrast, M31, C88 and E111, which are unaffected by ubiquitin, shift after hRpn2 (797-953) addition. Furthermore, when both Rpn2 and ubiquitin were added, S55, F76 and D78 contact ubiquitin whereas M31, C88 diubiquitin by Rpn13 Pru allows Uch37 access to the distal subunit. a, Comparison of spectra acquired with monoubiquitin versus K48-linked tetraubiquitin reveals identical effects for Rpn13's L56, F76 and F98 but differences for L73 and R104. Monoubiquitin (red) or tetraubiquitin (cyan) was added to hRpn13, which was monitored by 1 H, 15 N heteronuclear singlequantum coherence experiments. The spectrum of free hRpn13 is indicated in black, and the molar ratio of monoubiquitin (red) or tetraubiquitin (cyan) to hRpn13 was 1:1 in the represented spectra. b, Computer-generated model of the mRpn13 Pru-diubiquitin complex. White and grey ribbon diagrams display the proximal and distal ubiquitin, respectively, whereas a balls-andsticks representation is used for the K48-G76 isopeptide bond linkage. Rpn13 Pru is coloured in yellow and loops recognizing ubiquitin in blue, whereas L73, K103 and R104 are displayed in red. Diubiquitin was created by Insight II software based on atomic coordinates for the mRpn13 Pru-ubiquitin complex and monoubiquitin (PDB entry 1D3Z). In this model, the distal subunit of diubiquitin is positioned arbitrarily, as its only constraints prohibit steric clashes with other atoms. c, hRpn13 Pru interacts with the I44 d 1 and A46 methyl groups of the proximal subunit. 1 H, 13 C heteronuclear multiple-quantum coherence spectra were acquired on samples containing either no (black) or equimolar unlabelled hRpn13 (amino acids 1-150) (red) mixed with diubiquitin in which its proximal (left) or distal (right) subunit is labelled with 13 C. The shifted resonances are labelled. d, Model for how Rpn13 participates in Uch37 deconjugation of ubiquitinated substrates. Rpn13's C-terminal domain (grey) binds Uch37 (orange) as its N-terminal domain binds the polyubiquitin chain and Rpn2/ S1 (yellow). In this model, Uch37 binds to the distal subunit (light blue) of the chain while Rpn13 binds the proximal subunit (dark blue).
and E111 contact Rpn2 (Fig. 2d) , indicating that the two binding surfaces are largely independent. M31, C88 and E111 are conserved in mRpn13 and map to S1, the S5-S6 loop, and the region linking S7 to H1, respectively. These elements are clustered in a region that is opposite to the ubiquitin-binding loops of Rpn13.
26S proteasomes exhibit high affinity for ubiquitinated substrates. Ubiquitin chains linked by isopeptide bonds between K48 and the C-terminal glycine of neighbouring ubiquitin molecules are known to trigger proteasomal degradation of the labelled protein 14, 15 . We found that Rpn13 Pru binds K48-linked tetraubiquitin in a manner comparable to that of monoubiquitin. More specifically, tetraubiquitin and monoubiquitin caused chemical-shift changes to the same hRpn13 residues (Supplementary Fig. 6a ), including L56, F76 and F98, and shifted them almost identically (Fig. 3a) . Only two residues in hRpn13 exhibit changes that are specific to K48-linked tetraubiquitin, namely L73 and R104 (Fig. 3a and Supplementary Fig. 6a,  red) . These residues and the side-chain atoms of neighbouring K103 are proximal to each other; in the mRpn13-monoubiquitin structure they are directed towards the side-chain atoms of K48. This arrangement is congruent with Rpn13 binding the proximal subunit of diubiquitin, namely that which forms an isopeptide using K48 (Fig. 3b) . We tested this model further by monitoring the side-chain atoms of the proximal or distal subunit of diubiquitin upon addition of hRpn13 Pru. More specifically, unlabelled hRpn13 Pru was added to diubiquitin with either its proximal or distal subunit 13 C labelled, and the effect recorded by 1 H, 13 C heteronuclear multiple-quantum coherence experiments. Significant resonance shifting characteristic of hRpn13 binding was observed for the I44 c 1 , I44 d 1 and A46 methyl groups of the proximal subunit (Fig. 3c, left panel, and Supplementary Fig. 7a) . By contrast, resonances of the distal subunits exhibited only minor perturbations, most likely because of loss of intramolecular interactions with the proximal subunit. These data provide strong evidence that the major contacts formed between hRpn13 Pru and diubiquitin involve residues of the proximal subunit, at least when these two proteins are at equimolar concentration. Further evidence of this binding mode is provided by analytical ultracentrifugation data, which revealed 1:1 binding stoichiometry between hRpn13 Pru and diubiquitin (Supplementary Fig. 7b ).
In conclusion, we reveal that the ubiquitin-binding region of proteasome subunit Rpn13 adopts a PHD fold, and we solve its structure complexed with ubiquitin to unveil a new ubiquitin-binding mode. PHDs are present in a remarkably large number of proteins 16 , but Rpn13 Pru is the first example of a PHD structure within the 26S proteasome. Rpn13, like many other ubiquitin receptors, binds to the L8, I44 and V70 hydrophobic pocket of ubiquitin (Fig. 2b) . However, it is the first to bind this region using exclusively loops (Fig. 4a) . Most of the ubiquitin receptors characterized so far use a-helices to bind this surface of ubiquitin, including the ubiquitin-associated (UBA)-domain, coupling ubiquitin to endoplasmic reticulum degradation (CUE)-domain, ubiquitin-interacting motif (UIM), double-sided UIM (DUIM), inverted UIM (MIU), as well as GAT (GGA and TOM)-binding motifs (GGA, golgi-localized, c-ear-containing, Arf (ADP-ribosylation factor)-binding protein; TOM, target of Myb). Among them, the UBA and CUE domains are structurally homologous, with a common three-helical bundle architecture. Cue2-1 cue binds ubiquitin through the a1 and a3 helices (Fig. 4b) 10 , whereas the Dsk2 UBA uses the loop between a1 and a2, as well as the C-terminal part of a3 (Fig. 4c) 11 . Structural characterization of the UIMs demonstrated that a single a-helix is sufficient for binding this region of ubiquitin [17] [18] [19] . The UIM helix includes a conserved alanine neighboured by a bulky hydrophobic residue, each of which packs against ubiquitin's I44 as demonstrated in the S5a UIM1-ubiquitin complex (Fig. 4d) 19 . Rabex-5 MIU/IUIM 20, 21 and the polymerase g ubiquitin-binding zinc finger domain 22 similarly bind this region in ubiquitin through a single a-helix, but in the reverse orientation (Fig. 4e) . The GLUE domain of ESCRT-II EAP45, which exhibits a split pleckstrin-homology topology, is the only previously known ubiquitin-binding PHD 23 . However, it binds ubiquitin in a different manner: the I44-containing surface of ubiquitin is contacted by residues within secondary structural elements including the EAP45 C-terminal helix corresponding to H1 in Rpn13 23 ( Fig. 4f) . Moreover, although the longer S6-S7 loop of EAP45 is involved in binding ubiquitin, the S2-S3 and S4-S5 loops are not; instead, contacts are formed by residues from S5 and S6.
In addition to its unique monoubiquitin-binding mode, we have demonstrated that Rpn13 has a novel preference for diubiquitin elements within K48-linked chains 8 and that it most likely interacts directly with the isopeptide bond within a ubiquitin chain. This ubiquitin-binding mode is consistent with Rpn13's functional relationship with Uch37, which it adds to the collection of chainprocessing enzymes in the proteasome's regulatory particle [4] [5] [6] . For diubiquitin, hRpn13 binding to the proximal subunit would leave the distal one available to interact with Uch37 (Fig. 3d) . Evidence exists for Uch37 binding to the distal subunit of polyubiquitin; it is reported to be incapable of disassembling ubiquitin chains in which the distal ubiquitin contains the L8A and I44A mutations 24 and dismantles chains by removing one ubiquitin moiety at a time from the 26 and Rpn11 performs 'en bloc' deubiquitination from the proximal end 27, 28 . Deubiquitinating activities, particularly that of Ubp6, are antagonized by another regulatory particle component, the chain elongation factor Hul5 29 . With so many receptors and chain-processing enzymes within the regulatory particle, the detailed pathway by which a substrate is degraded may be subject to many stochastic variations. Whether this unanticipated design promotes high substrate flux through the proteasome is unclear, but it seems well suited to allow the cell to fine-tune proteasome activity.
METHODS SUMMARY
Expression, purification, crystallization and structure determination of mRpn13 Pru. mRpn13 Pru was overexpressed in Escherichia coli strain BL21(DE3) RIL (Stratagene) and purified by GST-affinity chromatography using a PreScission Protease (GE Healthcare) cleavage site followed by sizeexclusion chromatography. Rpn13 Pru was crystallized by the hanging-drop vapour-diffusion method and frozen in a stream of liquid nitrogen during X-ray exposure. Single anomalous dispersion methods were performed using synchrotron radiation at the BW6 beamline at the DESY-centre in Hamburg, Germany. Native data were collected to 1.7-Å resolution (Supplementary Table  1 ). Details about recombinant DNA modifications, expression and purification of mutant forms of Rpn13 Pru, data processing, phase determination, model building and structural refinement are described in Supplementary Information. NMR spectroscopy. Chemical shift assignments and spectra were acquired as described in Supplementary Information. mRpn13 Pru-ubiquitin and mRpn13 Pru-diubiquitin complexes were generated as described in Supplementary Information.
